- According to Transparency Market Research’s latest report on the global pain management therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, high incidence of chronic pain disorders, easy and effective medications, and higher demand of pain management products are projected to drive the global pain management therapeutics market during the forecast period
- According to the report, the global pain management therapeutics market was valued at US$ 66.6 Bn in 2018 and is anticipated to expand at a CAGR of 3.7% from 2019 to 2027
To know the scope of our report Get a Sample on Pain Management Therapeutics Market
Rise in Incidence of Chronic Pain Disorders to Promote Usage of Pain Management Therapeutics: Key Drivers
- The number of patients suffering from chronic pain is on a constant rise globally. For instance, according to the World Health Organization (WHO), the U.S. had 50 million people suffering from chronic pain in 2018. Additionally, according to a European Pain Federation, around 80 Mn adults in Europe suffers from chronic pain.
- The global increasing incidence rates of cancer further contribute to the rise in demand for pain management therapeutics. This includes pain occurring from cancer therapy as well as from incursion of cancer cells on to bones and other healthy body parts. WHO projections suggest that the global cancer prevalence will increase by around 75% from 2008 to 2030.
- Hence, increase in incidence of chronic pain conditions continue to encourage the use of pain management drugs, thereby driving the market.
Get a glimpse of the in-depth analysis through our Report Brochure
Easy & Effective Medications and Higher Demand of c Growth
- Doctors usually prescribe medicines in the initial stages of pain, followed by other treatment options. Prescription drugs are easy and economical to use at individual level without any ambiguity.
- Increased awareness about availability of medications for pain management propels consumption and acceptance of pain management drugs over other treatment options. Hence, high availability, easy access, high awareness, cost effectiveness, and quick relief have made pain management therapeutics more preferable to other treatment options.
- According to National Prescription Audit (May 2019), pain treatment was the fourth largest therapy in the U.S., with about 447 million prescriptions after lipid regulators.
- However, prescription volume for pain therapy decreased by 4.5% in 2018 as compared to 2017, due to continued implementation of control on volume of dispensing prescriptions for narcotic or opioid pain medicines, thereby reducing the misuse of drugs for non-medical use
Side Effects and Risk of drug abuse with opioids to Hamper Market
- The common side effects experienced from long-term usage of pain therapeutics include constipation, drowsiness, and respiratory depression. Commonly used NSAIDs for pain management have high risk of gastrointestinal ulceration or bleeding. COX-2 inhibitors were developed to eliminate this risk; however, these led to other issues such as risk of heart attack and stroke due to prolonged use.
- Prescription drug abuse poses a serious threat to the growth of the pain management therapeutics market due to its harmful long term effects. For instance as per National Institute Drug Abuse USA, more than 2 million people in the United States suffer from substance use disorders related to prescription opioid pain relievers.
Expanding operations in future? To get the perfect launch ask for a custom report
Global Pain Management Therapeutics Market: Competitive Landscape
- This report profiles major players in the global pain management therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global pain management therapeutics market is highly fragmented, with the presence of a number of international as well as regional players
- Leading players operating in the global pain management therapeutics market are
- Pfizer Inc.
- Depomed, Inc.
- Endo International plc.
- Purdue Pharma L.P.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- AstraZeneca plc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- GlaxoSmithKline plc.
Global Pain Management Therapeutics Market: Key Developments
Key players in the global pain management therapeutics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global pain management therapeutics market. A few expansion strategies adopted by players operating in the global pain management therapeutics market are:
- In March 2020, Pfizer Inc. and Eli Lilly and Company received USFDA approval for Tanezumab 2.5 mg administered subcutaneously (SC) in the treatment of chronic pain due to moderate-to-severe osteoarthritis (OA).
- In November 2019, Novartis AG received USFDA approval Adakveo for pain management in adult and pediatric patients aged 16 years and older with sickle cell disease.
The report on the global pain management therapeutics market discussed individual strategies, followed by company profiles of manufacturers of pain management therapeutics. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global pain management therapeutics market.
Global Pain Management Therapeutics Market - Segmentation
|
Therapeutics |
Anticonvulsants Antidepressants Anesthetics NSAIDS Opioids
Antimigraine Agents Other Non-narcotic Analgesic Anticonvulsants |
|
Indication |
Neuropathic Pain Fibromyalgia Arthritic Pain Chronic Back Pain Migraine Post-Operative Pain Cancer Pain |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Frequently Asked Questions
What is the total market worth of pain management therapeutics market?
The global pain management therapeutics market was worth US$ 66,558.6 Mn and is projected to reach a value of US$ 92,123.4 Mn by the end of 2027
What is the anticipated CAGR of the pain management therapeutics market in the forecast period?
Pain management therapeutics market is anticipated to grow at a CAGR of 3.7% during the forecast period
Which region is expected to project the highest market share in the global pain management therapeutics market?
North America accounted for a major share of the global pain management therapeutics market
What are the key driving factors for the growth of the pain management therapeutics market?
Pain management therapeutics market is driven by high incidence of chronic pain disorders, easy and effective medications, and higher demand of pain management products are projected to drive the global market during the forecast period
Who are the key players in the global pain management therapeutics market?
Key players in the global pain management therapeutics market include Pfizer Inc., Depomed, Inc., Endo International plc. , Purdue Pharma L.P., Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott Laboratories, GlaxoSmithKline plc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pain Management Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pain Management Therapeutics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Chronic Pain Disease Epidemiology, by Region/Major Countries
5.2. Pipeline Analysis
5.3. Brand Analysis
5.4. Most Types of Body Pain Location Globally and Cut By Gender and Parents
5.5. Most Types of Head Pain Location Globally and Cut By Gender and Parents
6. Global Pain Management Therapeutics Market Analysis and Forecast, by Type
7. Global Pain Management Therapeutics Market Analysis, By Therapeutics
7.1. Introduction
7.2. Global Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
7.3. Global Pain Management Therapeutics Market Forecast, by Therapeutics
7.3.1. Anticonvulsants
7.3.2. Antidepressants
7.3.3. Anesthetics
7.3.4. NSAIDS
7.3.5. Opioids
7.3.5.1. Oxycodones
7.3.5.2. Hydrocodones
7.3.5.3. Tramadol
7.3.5.4. Others
7.3.6. Antimigraine Agents
7.3.7. Other Non-narcotic Analgesic
7.4. Global Pain Management Therapeutics Market Analysis, by Therapeutics
8. Global Pain Management Therapeutics Market Analysis, By Indication
8.1. Introduction
8.2. Global Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
8.3. Global Pain Management Therapeutics Market Forecast, by Indication
8.3.1. Neuropathic Pain
8.3.2. Fibromyalgia
8.3.3. Arthritic Pain
8.3.4. Chronic Back Pain
8.3.5. Migraine
8.3.6. Post-Operative Pain
8.3.7. Cancer Pain
8.4. Global Pain Management Therapeutics Market Analysis, by Indication
9. Global Pain Management Therapeutics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Pain Management Therapeutics Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Pain Management Therapeutics Market Attractiveness, by Region
10. North America Pain Management Therapeutics Market Analysis
10.1. Key Findings
10.2. North America Pain Management Therapeutics Market Overview
10.3. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country
10.4. North America Pain Management Therapeutics Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
10.6. North America Pain Management Therapeutics Market Forecast, by Therapeutics
10.6.1. Anticonvulsants
10.6.2. Antidepressants
10.6.3. Anesthetics
10.6.4. NSAIDS
10.6.5. Opioids
10.6.5.1. Oxycodones
10.6.5.2. Hydrocodones
10.6.5.3. Tramadol
10.6.5.4. Others
10.6.6. Antimigraine Agents
10.6.7. Other Non-narcotic Analgesic
10.7. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
10.8. North America Pain Management Therapeutics Market Forecast, by Indication
10.8.1. Neuropathic Pain
10.8.2. Fibromyalgia
10.8.3. Arthritic Pain
10.8.4. Chronic Back Pain
10.8.5. Migraine
10.8.6. Post-Operative Pain
10.8.7. Cancer Pain
11. Europe Pain Management Therapeutics Market Analysis
11.1. Key Findings
11.2. Europe Pain Management Therapeutics Market Overview
11.3. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.4. Europe Pain Management Therapeutics Market Forecast, by Country/Sub-region
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
11.6. Europe Pain Management Therapeutics Market Forecast, by Therapeutics
11.6.1. Anticonvulsants
11.6.2. Antidepressants
11.6.3. Anesthetics
11.6.4. NSAIDS
11.6.5. Opioids
11.6.5.1. Oxycodones
11.6.5.2. Hydrocodones
11.6.5.3. Tramadol
11.6.5.4. Others
11.6.6. Antimigraine Agents
11.6.7. Other Non-narcotic Analgesic
11.7. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
11.8. Europe Pain Management Therapeutics Market Forecast, by Indication
11.8.1. Neuropathic Pain
11.8.2. Fibromyalgia
11.8.3. Arthritic Pain
11.8.4. Chronic Back Pain
11.8.5. Migraine
11.8.6. Post-Operative Pain
11.8.7. Cancer Pain
12. Asia Pacific Pain Management Therapeutics Market Analysis
12.1. Key Findings
12.2. Asia Pacific Pain Management Therapeutics Market Overview
12.3. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.4. Asia Pacific Pain Management Therapeutics Market Forecast, by Country/Sub-region
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
12.6. Asia Pacific Pain Management Therapeutics Market Forecast, by Therapeutics
12.6.1. Anticonvulsants
12.6.2. Antidepressants
12.6.3. Anesthetics
12.6.4. NSAIDS
12.6.5. Opioids
12.6.5.1. Oxycodones
12.6.5.2. Hydrocodones
12.6.5.3. Tramadol
12.6.5.4. Others
12.6.6. Antimigraine Agents
12.6.7. Other Non-narcotic Analgesic
12.7. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
12.8. Asia Pacific Pain Management Therapeutics Market Forecast, by Indication
12.8.1. Neuropathic Pain
12.8.2. Fibromyalgia
12.8.3. Arthritic Pain
12.8.4. Chronic Back Pain
12.8.5. Migraine
12.8.6. Post-Operative Pain
12.8.7. Cancer Pain
13. Latin America Pain Management Therapeutics Market Analysis
13.1. Key Findings
13.2. Latin America Pain Management Therapeutics Market Overview
13.3. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.4. Latin America Pain Management Therapeutics Market Forecast, by Country/Sub-region
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
13.6. Latin America Pain Management Therapeutics Market Forecast, by Therapeutics
13.6.1. Anticonvulsants
13.6.2. Antidepressants
13.6.3. Anesthetics
13.6.4. NSAIDS
13.6.5. Opioids
13.6.5.1. Oxycodones
13.6.5.2. Hydrocodones
13.6.5.3. Tramadol
13.6.5.4. Others
13.6.6. Antimigraine Agents
13.6.7. Other Non-narcotic Analgesic
13.7. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
13.8. Latin America Pain Management Therapeutics Market Forecast, by Indication
13.8.1. Neuropathic Pain
13.8.2. Fibromyalgia
13.8.3. Arthritic Pain
13.8.4. Chronic Back Pain
13.8.5. Migraine
13.8.6. Post-Operative Pain
13.8.7. Cancer Pain
14. Middle East & Africa Pain Management Therapeutics Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Pain Management Therapeutics Market Overview
14.3. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.4. Middle East & Africa Pain Management Therapeutics Market Forecast, by Country/Sub-region
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East & Africa
14.5. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics
14.6. Middle East & Africa Pain Management Therapeutics Market Forecast, by Therapeutics
14.6.1. Anticonvulsants
14.6.2. Antidepressants
14.6.3. Anesthetics
14.6.4. NSAIDS
14.6.5. Opioids
14.6.5.1. Oxycodones
14.6.5.2. Hydrocodones
14.6.5.3. Tramadol
14.6.5.4. Others
14.6.6. Antimigraine Agents
14.6.7. Other Non-narcotic Analgesic
14.7. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication
14.8. Middle East & Africa Pain Management Therapeutics Market Forecast, by Indication
14.8.1. Neuropathic Pain
14.8.2. Fibromyalgia
14.8.3. Arthritic Pain
14.8.4. Chronic Back Pain
14.8.5. Migraine
14.8.6. Post-Operative Pain
14.8.7. Cancer Pain
15. Competition Landscape
15.1. Market Player - Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Pfizer Inc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. Depomed, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. Endo International plc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Mankind Pharma Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Merck & Co, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. Pfizer, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. Teva Pharmaceutical Industries Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Lupin Limited
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Piramal Enterprises
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis
15.3.10. Syzygy Healthcare LLC
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
List of Table
Table 1 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 2 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 3 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 4 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 5 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 6 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 7 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 8 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 9 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 11 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 12 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 13 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 15 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 16 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 17 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 19 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 20 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 21 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027
Table 23 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027
Table 24 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027
List of Figure
Figure 1 Global Pain Management Therapeutics Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 2 Global Pain Management Therapeutics Market Value (US$ Mn) and Forecast, 2019–2027
Figure 3 Global Pain Management Therapeutics Market Value Share (%), by Therapeutics, 2018
Figure 4 Global Pain Management Therapeutics Market Value Share (%), by Indication, 2018
Figure 5 Global Pain Management Therapeutics Market Value Share (%), by Region, 2018
Figure 6 Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 7 Global Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 8 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticonvulsants, 2017–2027
Figure 9 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antidepressants, 2017–2027
Figure 10 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anesthetics, 2017–2027
Figure 11 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by NSAIDS, 2017–2027
Figure 12 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2017–2027
Figure 13 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antimigraine Agents, 2017–2027
Figure 14 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Non-narcotic Analgesic, 2017–2027
Figure 15 Global Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 16 Global Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 17 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Neuropathic Pain, 2017–2027
Figure 18 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fibromyalgia, 2017–2027
Figure 19 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arthritic Pain, 2017–2027
Figure 20 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chronic Back Pain, 2017–2027
Figure 21 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Migraine, 2017–2027
Figure 22 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-Operative Pain, 2017–2027
Figure 23 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Pain, 2017–2027
Figure 24 Global Pain Management Therapeutics Market Value Share, by Region, 2018 and 2027
Figure 25 Global Pain Management Therapeutics Market Attractiveness, by Region, 2019–2027
Figure 26 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 27 North America Pain Management Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
Figure 28 North America Pain Management Therapeutics Market Attractiveness, by Country, 2019–2027
Figure 29 North America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 30 North America Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 31 North America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 32 North America Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 33 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 34 Europe Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 35 Europe Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 36 Europe Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 37 Europe Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 38 Europe Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 39 Europe Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 40 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 41 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 43 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 44 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 45 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 46 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 47 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 48 Latin America Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 49 Latin America Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 50 Latin America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 51 Latin America Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 52 Latin America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 53 Latin America Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 54 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 55 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 56 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 57 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027
Figure 58 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027
Figure 59 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027
Figure 60 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027
Figure 61 Global Pain Management Therapeutics Market Share Analysis, by Company, 2018
